SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections

Hassoun-Kheir, N; Redin, MR; Labi, A-K; Loftus, M; Stewardson, AJ; Harbarth, S; Leibovici, L; Paul, M; Pouwels, KB; Sharland, M; et al. Hassoun-Kheir, N; Redin, MR; Labi, A-K; Loftus, M; Stewardson, AJ; Harbarth, S; Leibovici, L; Paul, M; Pouwels, KB; Sharland, M; Aiken, AM; de Kraker, MEA (2025) Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections. Clinical Microbiology and Infection, 31 (12). pp. 1972-1979. ISSN 1198-743X https://doi.org/10.1016/j.cmi.2025.07.033
SGUL Authors: Sharland, Michael Roy

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (653kB)
[img] Microsoft Word (.docx) (Multimedia component 1) Supporting information
Download (233kB)

Abstract

BACKGROUND: Antimicrobial resistance increases the risk of misaligned initial antibiotic treatment (IAT), as susceptibility data are typically delayed. The causal effect on patient outcomes, however, is unclear due to reliance on observational studies with methodological heterogeneity. OBJECTIVES: To describe the terminology and definitions for IAT misalignment and evaluate methods used to analyse its association with mortality and hospital length of stay (LOS) for patients with drug-resistant bloodstream infections (BSIs). METHODS: A systematic review. DATA SOURCES: PubMed and EMBASE: January 1990 to August 2024. STUDY ELIGIBILITY CRITERIA: We included studies on drug-resistant BSIs caused by ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species, and other Enterobacterales). Eligible studies defined IAT misalignment and assessed its effect on mortality/LOS. PARTICIPANTS: Patients with drug-resistant BSIs. EXPOSURE: (mis)aligned IAT. ASSESSMENT OF RISK OF BIAS: Revised versions of the Joanna Briggs Institute tools. METHODS OF DATA SYNTHESIS: Qualitative synthesis. RESULTS: From 3627 screened publications, 187 studies were included, predominantly cohort studies (n = 183). The most common terminology for IAT misalignment was "(in)appropriate" (n = 139, 74.3%), followed by "(in)adequate" (n = 34, 18.2%). Definitions primarily considered in vitro susceptibility to prescribed antibiotic(s) (n = 184, 98.4%), with up to nine additional criteria. Impact of (in)appropriate IAT on mortality (n = 186) was mostly evaluated using logistic or Cox regression, including various confounder selection methods, showing an association in 122 of 186 studies (65.6%). Admission-to-infection time and infection-to-treatment time were rarely considered. Impact of (in)appropriate IAT on LOS was shown in two of nine studies. Only four studies explicitly analysed postinfection LOS. No study scored a low risk of bias, due to residual confounding and time-dependent bias. DISCUSSION: Wide variability of IAT definitions and impact analysis was observed, with a high risk of bias, hindering data aggregation and limiting understanding of the causal effect of inappropriate IAT on clinical outcomes. Guidelines are required to improve study quality and harmonize future research.

Item Type: Article
Additional Information: © 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Analytical methodology, Antimicrobial resistance, Bias, Bloodstream infection, Causal inference, Inappropriate initial antibiotic treatment, Humans, Anti-Bacterial Agents, Bacteremia, Length of Stay, Terminology as Topic, Drug Resistance, Bacterial, Treatment Outcome
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Clinical Microbiology and Infection
ISSN: 1198-743X
Language: en
Media of Output: Print-Electronic
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
101034420Innovative Medicines Initiativehttps://doi.org/10.13039/501100010767
18142European Society of Clinical Microbiology and Infectious Diseaseshttp://dx.doi.org/10.13039/501100001704
INV-003519Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
222051/Z/20/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 40780552
Dates:
Date Event
2025-11-26 Published
2025-08-06 Published Online
2025-07-31 Accepted
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/118351
Publisher's version: https://doi.org/10.1016/j.cmi.2025.07.033

Actions (login required)

Edit Item Edit Item